RAVULIZUMAB vs ZILUCOPLAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RAVULIZUMAB vs ZILUCOPLAN: Safety Overview
| Metric | RAVULIZUMAB | ZILUCOPLAN |
|---|---|---|
| Total FAERS Reports | 118 | 441 |
| Deaths Reported | 11 | 23 |
| Death Rate | 9.3% | 5.2% |
| Hospitalizations | 89 | 163 |
| Average Patient Age | 48.4 yrs | 58.8 yrs |
| % Female Patients | 56.3% | 53.6% |
| FDA Approval Date | N/A | Oct 17, 2023 |
| Manufacturer | Alexion Pharmaceuticals Inc. | UCB, Inc. |
| Route | INTRAVENOUS | SUBCUTANEOUS |
| Marketing Status | N/A | Prescription |